CTOs on the Move

Transcend Health

www.transcend.healthcare

 
Transcend Health is a healthcare company that provides a digital health platform for first responders, encompassing health, physical fitness, training, and wellness. They also offer a Direct Primary Care model for employers to provide superior access t...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Walnut Hills Retirement Cmmty

Walnut Hills Retirement Cmmty is a Walnut Creek, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GuideWell

GuideWell Mutual Holding Corporation is a not-for-profit mutual holding company that is the parent to a family of forward-thinking companies focused on transforming health care.

Cape Medical Supply

Cape Medical Supply is a Sandwich, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Animale Parfums

Animale Parfums is a Hollywood, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sernova

Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.